Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.210
+0.050 (1.58%)
At close: Oct 2, 2025, 4:00 PM EDT
3.240
+0.030 (0.93%)
After-hours: Oct 2, 2025, 7:51 PM EDT

Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $346.37 million. The enterprise value is $100.08 million.

Market Cap346.37M
Enterprise Value 100.08M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

RCKT has 107.90 million shares outstanding. The number of shares has increased by 13.53% in one year.

Current Share Class 107.90M
Shares Outstanding 107.90M
Shares Change (YoY) +13.53%
Shares Change (QoQ) +0.84%
Owned by Insiders (%) 2.79%
Owned by Institutions (%) 66.66%
Float 78.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.98
P/TBV Ratio 1.19
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.07.

Current Ratio 6.39
Quick Ratio 6.26
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -139.85

Financial Efficiency

Return on equity (ROE) is -69.65% and return on invested capital (ROIC) is -41.81%.

Return on Equity (ROE) -69.65%
Return on Assets (ROA) -38.07%
Return on Invested Capital (ROIC) -41.81%
Return on Capital Employed (ROCE) -69.97%
Revenue Per Employee n/a
Profits Per Employee -$860,532
Employee Count299
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.25% in the last 52 weeks. The beta is 0.60, so RCKT's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -81.25%
50-Day Moving Average 3.19
200-Day Moving Average 6.28
Relative Strength Index (RSI) 49.83
Average Volume (20 Days) 2,178,936

Short Selling Information

The latest short interest is 14.89 million, so 13.80% of the outstanding shares have been sold short.

Short Interest 14.89M
Short Previous Month 15.49M
Short % of Shares Out 13.80%
Short % of Float 19.03%
Short Ratio (days to cover) 2.70

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -264.18M
Pretax Income -257.30M
Net Income -257.30M
EBITDA -253.87M
EBIT -264.18M
Earnings Per Share (EPS) -$2.49
Full Income Statement

Balance Sheet

The company has $271.49 million in cash and $25.20 million in debt, giving a net cash position of $246.29 million or $2.28 per share.

Cash & Cash Equivalents 271.49M
Total Debt 25.20M
Net Cash 246.29M
Net Cash Per Share $2.28
Equity (Book Value) 354.21M
Book Value Per Share 3.28
Working Capital 233.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$203.80 million and capital expenditures -$2.31 million, giving a free cash flow of -$206.11 million.

Operating Cash Flow -203.80M
Capital Expenditures -2.31M
Free Cash Flow -206.11M
FCF Per Share -$1.91
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.53%
Shareholder Yield -13.53%
Earnings Yield -74.28%
FCF Yield -59.51%
Dividend Details

Analyst Forecast

The average price target for RCKT is $12.96, which is 303.74% higher than the current price. The consensus rating is "Buy".

Price Target $12.96
Price Target Difference 303.74%
Analyst Consensus Buy
Analyst Count 13
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -24.42%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1